241 related articles for article (PubMed ID: 20105087)
1. Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
Bex A; Van der Veldt AA; Blank C; Meijerink MR; Boven E; Haanen JB
Acta Oncol; 2010 May; 49(4):520-3. PubMed ID: 20105087
[No Abstract] [Full Text] [Related]
2. The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
Cost NG; Delacroix SE; Sleeper JP; Smith PJ; Youssef RF; Chapin BF; Karam JA; Culp S; Abel EJ; Brugarolas J; Raj GV; Sagalowsky AI; Wood CG; Margulis V
Eur Urol; 2011 Jun; 59(6):912-8. PubMed ID: 21367518
[TBL] [Abstract][Full Text] [Related]
3. Targeted caval cytoreduction: solid foundations or shifting sands?
Bex A; Clarke N
Eur Urol; 2011 Jun; 59(6):919-20; discussion 921-2. PubMed ID: 21444147
[No Abstract] [Full Text] [Related]
4. [An image of vena cava thrombosis].
Viguier JB; Amraoui S; Solanilla A; Boulon C; Constans J; Conri C
J Mal Vasc; 2009 Nov; 34(5):372-3. PubMed ID: 19717254
[No Abstract] [Full Text] [Related]
5. Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombus.
Horn T; Thalgott MK; Maurer T; Hauner K; Schulz S; Fingerle A; Retz M; Gschwend JE; Kübler HR
Anticancer Res; 2012 May; 32(5):1729-35. PubMed ID: 22593453
[TBL] [Abstract][Full Text] [Related]
6. [A case of advanced renal cell carcinoma with inferior vena cava thrombus treated with sunitinib as neoadjuvant therapy].
Chiba H; Hirose T; Shimoda N; Kanagawa K
Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):623-6. PubMed ID: 23120997
[TBL] [Abstract][Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 17-2008. A 63-year-old man with metastatic renal-cell carcinoma.
Michaelson MD; Iliopoulos O; McDermott DF; McGovern FJ; Harisinghani MG; Oliva E
N Engl J Med; 2008 May; 358(22):2389-96. PubMed ID: 18509125
[No Abstract] [Full Text] [Related]
8. [Neoadjuvant therapy for renal cancer].
Thibault F; Rixe O; Meric JB; Renard-Penna R; Boostan H; Mozer P; Comperat E; Richard F; Bitker MO
Prog Urol; 2008 Apr; 18(4):256-8. PubMed ID: 18501308
[TBL] [Abstract][Full Text] [Related]
9. Endoluminal control of the inferior vena cava during resection of a level III tumor thrombus associated with renal cell carcinoma: a case report and review of the literature.
Kanka KC; Tabibian L; Alexander J
Vasc Endovascular Surg; 2010 Aug; 44(6):499-502. PubMed ID: 20519283
[TBL] [Abstract][Full Text] [Related]
10. Performing cytoreductive nephrectomy following targeted sunitinib therapy for metastatic renal cell carcinoma: a surgical perspective.
Shaw GL; Hussain M; Nair R; Bycroft J; Beltran L; Green JS; Powles T; Peters JL
Urol Int; 2012; 89(1):83-8. PubMed ID: 22614181
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib as adjuvant therapy for renal cell carcinoma.
Baker H
Lancet Oncol; 2016 Nov; 17(11):e485. PubMed ID: 27773485
[No Abstract] [Full Text] [Related]
12. Neoadjuvant Sunitinib Decreases Inferior Vena Caval Thrombus Size and Is Associated With Improved Oncologic Outcomes: A Multicenter Comparative Analysis.
Field CA; Cotta BH; Jimenez J; Lane BR; Yim K; Lee HJ; Ryan ST; Hamilton ZA; Patel S; Wang S; Kane CJ; Dey S; Mckay RR; Noyes S; Millard FE; Rini BI; Campbell SC; Derweesh IH
Clin Genitourin Cancer; 2019 Jun; 17(3):e505-e512. PubMed ID: 30808547
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography characteristics of unresectable primary renal cell carcinoma treated with neoadjuvant sunitinib.
Salem ME; Shah SN; Elson P; Garcia JA; Wood LS; Medsinge A; Campbell S; Dreicer R; Rini BI
Clin Genitourin Cancer; 2014 Apr; 12(2):117-23. PubMed ID: 24126239
[TBL] [Abstract][Full Text] [Related]
14. Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral nephron-sparing surgery.
Gorin MA; Ekwenna O; Soloway MS; Ciancio G
Urology; 2012 Feb; 79(2):e11. PubMed ID: 21676439
[TBL] [Abstract][Full Text] [Related]
15. Case study of the month. Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma.
Robert G; Gabbay G; Bram R; Wallerand H; Deminière C; Cornelis F; Bernhard JC; Ravaud A; Ballanger P
Eur Urol; 2009 Jun; 55(6):1477-80. PubMed ID: 19150171
[TBL] [Abstract][Full Text] [Related]
16. Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution.
Ujike T; Uemura M; Kawashima A; Nagahara A; Fujita K; Miyagawa Y; Nonomura N
Anticancer Drugs; 2016 Nov; 27(10):1038-43. PubMed ID: 27557138
[TBL] [Abstract][Full Text] [Related]
17. [A CASE OF RENAL CELL CARCINOMA WITH INFERIOR VENA CAVAL TUMOR THROMBUS WHICH THE REDUCTION OF TUMOR IN SPITE OF DRUG DISCONTINUANCE AFTER THE FULMINANT HEPATITIS ONSET WITH THE SUNITNIB].
Shichijo T; Koizumi S; Ogawa Y; Matsubara E; Matsumoto Y; Saito K; Inoue K; Ogawa Y; Samejima M; Odagane T; Ishihara M; Higaki Y
Nihon Hinyokika Gakkai Zasshi; 2018; 109(2):102-105. PubMed ID: 31006738
[TBL] [Abstract][Full Text] [Related]
18. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma.
Thomas AA; Rini BI; Lane BR; Garcia J; Dreicer R; Klein EA; Novick AC; Campbell SC
J Urol; 2009 Feb; 181(2):518-23; discussion 523. PubMed ID: 19100579
[TBL] [Abstract][Full Text] [Related]
19. [A case of recurrent intracaval renal cell carcinoma effectively treated with sunitinib].
Komeya M; Matsumoto T; Fujinami K; Senga Y; Asakura T; Goto A
Hinyokika Kiyo; 2010 Sep; 56(9):499-503. PubMed ID: 20940524
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
Karakiewicz PI; Suardi N; Jeldres C; Audet P; Ghosn P; Patard JJ; Perrotte P
Eur Urol; 2008 Apr; 53(4):845-8. PubMed ID: 18053636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
